Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the United States as Trilafon, it has been in clinical use for decades.
Applications & Measurement
Explore the main themes, entities and connections around Perphenazine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
antipsychotic may antipsychotics oral drug typical patients treatment phenothiazine chlorpromazine dose effects used symptoms clinical potent d2 drugs half-life bioavailability
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Perphenazine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Perphenazine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Perphenazine | ATC code | N05AB03 (WHO) | 1.00 | infobox |
| Perphenazine | Bioavailability | 40% | 1.00 | infobox |
| Perphenazine | CAS Number | 58-39-9 Y | 1.00 | infobox |
| Perphenazine | ChEBI | CHEBI:8028 Y | 1.00 | infobox |
| Perphenazine | ChEMBL | ChEMBL567 Y | 1.00 | infobox |
| Perphenazine | ChemSpider | 4586 Y | 1.00 | infobox |
| Perphenazine | CompTox Dashboard (EPA) | DTXSID1023441 | 1.00 | infobox |
| Perphenazine | Drug class | Typical antipsychotic | 1.00 | infobox |
| Perphenazine | DrugBank | DB00850 Y | 1.00 | infobox |
| Perphenazine | ECHA InfoCard | 100.000.346 | 1.00 | infobox |
| Perphenazine | Elimination half-life | 8–12 (up to 20) hours | 1.00 | infobox |
| Perphenazine | Formula | C21H26ClN3OS | 1.00 | infobox |
| Perphenazine | IUPHAR/BPS | 209 | 1.00 | infobox |
| Perphenazine | KEGG | D00503 Y | 1.00 | infobox |
| Perphenazine | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Perphenazine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Perphenazine | Legal status | US: ℞-only | 1.00 | infobox |
| Perphenazine | MedlinePlus | a682165 | 1.00 | infobox |
| Perphenazine | Metabolism | hepatic | 1.00 | infobox |
| Perphenazine | Molar mass | 403.97 g·mol−1 | 1.00 | infobox |
| Perphenazine | Pregnancy category | AU: C | 1.00 | infobox |
| Perphenazine | PubChem CID | 4748 | 1.00 | infobox |
| Perphenazine | Routes of administration | Oral and IM | 1.00 | infobox |
| Perphenazine | UNII | FTA7XXY4EZ | 1.00 | infobox |
| Perphenazine | causes | early and late extrapyramidal side effects more often than placebo | 0.90 | text |
| Perphenazine | is a | typical antipsychotic drug | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.